E. Krognes - Jan 7, 2025 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Jan 7, 2025
Transactions value $
-$69,485
Form type
4
Date filed
1/8/2025, 08:23 PM
Previous filing
Jan 2, 2025
Next filing
Feb 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$69.5K -3.34K -11.48% $20.81 25.8K Jan 7, 2025 Direct F1, F2
holding DNLI Common Stock 782K Jan 7, 2025 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
F2 Includes 5,967 Unvested RSUs.
F3 The shares are held of record by The Steve Edward Krognes Revocable Trust U/A DTD 01/25/2016, for which the Reporting Person serves as trustee.